Jerry Rosenbaum

Director, Center for Anxiety and Traumatic Stress Disorders (CATSD), Massachusetts General Hospital,
Summary
Dr. Jerry Rosenbaum is a distinguished figure in the field of psychiatry and neuroscience, known for his leadership and contributions to research and education in mental health.
He has had an illustrious career, leading a department of 600 clinicians and researchers, along with 150 trainees, at a top-ranked institution in the United States, recognized for its excellence in clinical and research programs.
Throughout his career, Dr. Rosenbaum has received numerous accolades, including the C. Charles Burlingame Award and the Joseph B. Martin Dean's Leadership Award, highlighting his lifetime achievements in psychiatric research and dedication to advancing women faculty in the medical field.
As a respected authority in the field, he has authored over 400 articles and reviews, as well as 20 books, focusing on longitudinal studies of children at risk for anxiety and depression, exploring various aspects of these disorders from behavioral differences to genetics and brain structure.
Dr. Rosenbaum's current endeavors include spearheading the establishment of The Center for Neuroscience of Psychedelics at Massachusetts General Hospital, aiming to enhance neuroplasticity through the use of psychedelics to revolutionize mental health treatments.
He is also involved in the co-founding of Psy Therapeutics, a company dedicated to advancing the discovery of innovative drugs and diagnostics for psychiatric disorders.
With a background in American Studies from Yale College and further studies at Yale University School of Medicine, Dr. Rosenbaum brings a multidisciplinary approach to his work in psychiatry and neuroscience, bridging the gap between different fields of expertise.